Prolonged Maternal Zika Viremia as a Marker of Adverse Perinatal Outcomes
Whether prolonged maternal viremia after Zika virus infection represents a risk factor for maternal–fetal transmission and subsequent adverse outcomes remains unclear. In this prospective cohort study in French Guiana, we enrolled Zika virus–infected pregnant women with a positive PCR result at inc...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2021-02-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/27/2/20-0684_article |
id |
doaj-24c03145ed18429d8fbce85d602a6f7d |
---|---|
record_format |
Article |
spelling |
doaj-24c03145ed18429d8fbce85d602a6f7d2021-01-25T12:43:11ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592021-02-0127249049810.3201/eid2702.200684Prolonged Maternal Zika Viremia as a Marker of Adverse Perinatal OutcomesLéo PomarVéronique LambertSéverine MatheusCéline PomarNajeh HciniGabriel CarlesDominique RoussetManon VougaAlice PanchaudDavid Baud Whether prolonged maternal viremia after Zika virus infection represents a risk factor for maternal–fetal transmission and subsequent adverse outcomes remains unclear. In this prospective cohort study in French Guiana, we enrolled Zika virus–infected pregnant women with a positive PCR result at inclusion and noninfected pregnant women; both groups underwent serologic testing in each trimester and at delivery during January–July 2016. Prolonged viremia was defined as ongoing virus detection >30 days postinfection. Adverse outcomes (fetal loss or neurologic anomalies) were more common in fetuses and neonates from mothers with prolonged viremia (40.0%) compared with those from infected mothers without prolonged viremia (5.3%, adjusted relative risk [aRR] 7.2 [95% CI 0.9–57.6]) or those from noninfected mothers (6.6%, aRR 6.7 [95% CI 3.0–15.1]). Congenital infections were confirmed more often in fetuses and neonates from mothers with prolonged viremia compared with the other 2 groups (60.0% vs. 26.3% vs. 0.0%, aRR 2.3 [95% CI 0.9–5.5]). https://wwwnc.cdc.gov/eid/article/27/2/20-0684_articleZikaprolonged viremiacongenital infectioncongenital Zika syndromevirusesmosquitoborne diseases |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Léo Pomar Véronique Lambert Séverine Matheus Céline Pomar Najeh Hcini Gabriel Carles Dominique Rousset Manon Vouga Alice Panchaud David Baud |
spellingShingle |
Léo Pomar Véronique Lambert Séverine Matheus Céline Pomar Najeh Hcini Gabriel Carles Dominique Rousset Manon Vouga Alice Panchaud David Baud Prolonged Maternal Zika Viremia as a Marker of Adverse Perinatal Outcomes Emerging Infectious Diseases Zika prolonged viremia congenital infection congenital Zika syndrome viruses mosquitoborne diseases |
author_facet |
Léo Pomar Véronique Lambert Séverine Matheus Céline Pomar Najeh Hcini Gabriel Carles Dominique Rousset Manon Vouga Alice Panchaud David Baud |
author_sort |
Léo Pomar |
title |
Prolonged Maternal Zika Viremia as a Marker of Adverse Perinatal Outcomes |
title_short |
Prolonged Maternal Zika Viremia as a Marker of Adverse Perinatal Outcomes |
title_full |
Prolonged Maternal Zika Viremia as a Marker of Adverse Perinatal Outcomes |
title_fullStr |
Prolonged Maternal Zika Viremia as a Marker of Adverse Perinatal Outcomes |
title_full_unstemmed |
Prolonged Maternal Zika Viremia as a Marker of Adverse Perinatal Outcomes |
title_sort |
prolonged maternal zika viremia as a marker of adverse perinatal outcomes |
publisher |
Centers for Disease Control and Prevention |
series |
Emerging Infectious Diseases |
issn |
1080-6040 1080-6059 |
publishDate |
2021-02-01 |
description |
Whether prolonged maternal viremia after Zika virus infection represents a risk factor for maternal–fetal transmission and subsequent adverse outcomes remains unclear. In this prospective cohort study in French Guiana, we enrolled Zika virus–infected pregnant women with a positive PCR result at inclusion and noninfected pregnant women; both groups underwent serologic testing in each trimester and at delivery during January–July 2016. Prolonged viremia was defined as ongoing virus detection >30 days postinfection. Adverse outcomes (fetal loss or neurologic anomalies) were more common in fetuses and neonates from mothers with prolonged viremia (40.0%) compared with those from infected mothers without prolonged viremia (5.3%, adjusted relative risk [aRR] 7.2 [95% CI 0.9–57.6]) or those from noninfected mothers (6.6%, aRR 6.7 [95% CI 3.0–15.1]). Congenital infections were confirmed more often in fetuses and neonates from mothers with prolonged viremia compared with the other 2 groups (60.0% vs. 26.3% vs. 0.0%, aRR 2.3 [95% CI 0.9–5.5]).
|
topic |
Zika prolonged viremia congenital infection congenital Zika syndrome viruses mosquitoborne diseases |
url |
https://wwwnc.cdc.gov/eid/article/27/2/20-0684_article |
work_keys_str_mv |
AT leopomar prolongedmaternalzikaviremiaasamarkerofadverseperinataloutcomes AT veroniquelambert prolongedmaternalzikaviremiaasamarkerofadverseperinataloutcomes AT severinematheus prolongedmaternalzikaviremiaasamarkerofadverseperinataloutcomes AT celinepomar prolongedmaternalzikaviremiaasamarkerofadverseperinataloutcomes AT najehhcini prolongedmaternalzikaviremiaasamarkerofadverseperinataloutcomes AT gabrielcarles prolongedmaternalzikaviremiaasamarkerofadverseperinataloutcomes AT dominiquerousset prolongedmaternalzikaviremiaasamarkerofadverseperinataloutcomes AT manonvouga prolongedmaternalzikaviremiaasamarkerofadverseperinataloutcomes AT alicepanchaud prolongedmaternalzikaviremiaasamarkerofadverseperinataloutcomes AT davidbaud prolongedmaternalzikaviremiaasamarkerofadverseperinataloutcomes |
_version_ |
1724324334221131776 |